Probiotic Bacillus coagulans GBI-30, 6086 Improves Protein Absorption and Utilization

Probiotics and Prebiotics: Present Status and Future Perspectives on Metabolic Disorders

(2016) Ji Yoo et al.   Nutrients

ProbioticBacillus coagulansGBI-30, 6086 reduces exercise-induced muscle damage and increases recovery

(2016) Ralf Jäger et al.   PeerJ

Bacillus coagulans GBI-30, 6086 Modulates Faecalibacterium prausnitzii in Older Men and Women

(2015) Edna P Nyangale et al.   JOURNAL OF NUTRITION

Powdered tart cherry supplementation surrounding a single bout of intense resistance exercise demonstrates potential attenuation of recovery strength decrement with no definitive oxidative or inflammatory effect

(2015) K Levers et al.   Journal of the International Society of Sports Nutrition

Effect of prebiotics on the fecal microbiota of elderly volunteers after dietary supplementation of Bacillus coagulans GBI-30, 6086

(2014) Edna P. Nyangale et al.   ANAEROBE

Probiotics supplementation for athletes – Clinical and physiological effects

(2014) David B. Pyne et al.   European Journal of Sport Science

The effects of probiotic supplementation on lean body mass, strength, and power, and health indicators in resistance trained males: a pilot study

(2014) John Georges et al.   Journal of the International Society of Sports Nutrition

Therapeutic Modulation of Microbiota-Host Metabolic Interactions

(2012) E. Holmes et al.   Science Translational Medicine

One-year chronic oral toxicity with combined reproduction toxicity study of a novel probiotic, Bacillus coagulans, as a food ingredient

(2011) J.R. Endres et al.   FOOD AND CHEMICAL TOXICOLOGY

Use of a continuous culture fermentation system to investigate the effect of GanedenBC30 (Bacillus coagulans GBI-30, 6086) supplementation on pathogen survival in the human gut microbiota

(2010) Harue Honda et al.   ANAEROBE

GanedenBC30™ cell wall and metabolites: anti-inflammatory and immune modulating effects in vitro

(2010) Gitte S Jensen et al.   BMC IMMUNOLOGY

Effects of a propietary Bacillus coagulans preparation on symptoms of diarrhea-predominant irritable bowel syndrome

(2010) B.J. Dolin   METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY

A prospective, randomized, double-blind, placebo-controlled parallel-group dual site trial to evaluate the effects of a Bacillus coagulans-based product on functional intestinal gas symptoms

(2009) Douglas S Kalman et al.   BMC GASTROENTEROLOGY

Safety assessment of a proprietary preparation of a novel Probiotic, Bacillus coagulans, as a food ingredient

(2009) J.R. Endres et al.   FOOD AND CHEMICAL TOXICOLOGY

Original Research:Bacillus coagulansSignificantly Improved Abdominal Pain and Bloating in Patients with IBS

(2009) Larysa Hun   POSTGRADUATE MEDICINE

Survival and metabolic activity of the GanedenBC30 strain of Bacillus coagulans in a dynamic in vitro model of the stomach and small intestine

(2009) A. Maathuis et al.   Beneficial Microbes